September issue of 'Global Fund News Flash' email newsletter available

Sep 21 2012NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria has published Issue 8 of its newsletter, the "Global Fund News Flash." The issue reports on the Board's approval of a new funding approach; says "the Board extended the mandate of the Global Fund to host the Affordable Medicines Facility-malaria for another year after the end of its pilot phase in December"; notes the fund adopted a code of conduct for grant recipients; and profiles Linda Mafu, head of civil society and political advocacy at the Global Fund (9/20).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News

Tags: , , , ,

Comments (0)

Suggested Reading

Study finds artemisinin resistance in African children with severe malaria
TB pathogen's surprising growth mechanism challenges bacterial biology
Study finds high risk of pediatric tuberculosis in high-burden areas
Maternal antibodies may hinder malaria vaccine effectiveness in infants
Malaria crystal structure offers clues for more effective medications
Deforestation drives a surge in malaria cases in the Amazon
Artemisinin resistance detected in children with severe malaria in Uganda
A promising new strategy for malaria drug development

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New test promises to end malaria